Related Experiment Video

Updated: Apr 12, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Is there a role for screening asymptomatic patients with diabetes?

Mahdi Veillet-Chowdhury1, Ron Blankstein

  • 1Brigham and Women's Hospital, 75 Francis Street, Shapiro Cardiovascular Center, Boston, MA 02115, USA.

Expert Review of Cardiovascular Therapy
|May 17, 2015
PubMed

Insights

Coronary artery disease (CAD) screening in asymptomatic diabetics using non-invasive imaging yielded negative results. Optimal medical management remains key for reducing cardiovascular events in this population.

Area of Science:

  • Cardiology
  • Diabetology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) is a major cause of mortality in diabetic patients, often presenting without symptoms.
  • Asymptomatic individuals with diabetes and CAD may experience myocardial infarction as their first CAD manifestation.
  • Non-invasive cardiovascular imaging can detect CAD presence, severity, and hemodynamic impact.

Discussion:

  • The Detection of Ischemia in Asymptomatic Diabetics and FACTOR-64 studies evaluated non-invasive imaging for asymptomatic diabetics.
  • Trial results did not support routine CAD screening in asymptomatic diabetic patients.
  • These findings reinforce the importance of optimal medical management for cardiovascular event reduction.

Key Insights:

  • Non-invasive imaging utility for asymptomatic diabetic CAD screening is limited.
  • Optimal medical management is crucial for mitigating cardiovascular risks in diabetics.
  • Further trials focusing on high-risk CAD patients with silent ischemia may inform revascularization benefits.

Outlook:

  • Future research could explore the prognostic benefits of coronary revascularization in high-risk diabetic patients with silent ischemia.
  • Continued emphasis on optimal medical therapy is essential for managing cardiovascular risk in diabetes.
  • Investigating specific high-risk subgroups may refine screening and treatment strategies.

Keywords:
asymptomaticcalcium scorecoronary CTdiabetesimaging

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.2K
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

7.1K

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
984